Nicotrol Inhaler Behind-The-Counter Status Sought By Pharmacist Group
This article was originally published in The Tan Sheet
FDA should allow Pfizer's Rx Nicotrol Inhaler to be sold by pharmacists from behind the counter, according to a citizen petition filed by Pharmacists Planning Service, Inc
You may also be interested in...
Nonsedating antihistamines classified as prescription drugs would be more appropriately sold as OTCs, Blue Cross of California Pharmacy VP Rob Seidman maintains in Jan. 12 letters sent to marketers of the drugs.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning